Ran Furman

Ran Furman is an experienced biochemist and scientific leader with a robust background in drug discovery and development. Currently serving as the Head of Discovery and Preclinical at Neurim Pharmaceuticals Ltd since September 2022, Ran leads target identification efforts for new drug candidates and manages the company's R&D program, overseeing patents and communication with academic labs and Contract Research Organizations. Previous roles include Senior Scientist at Bristol-Myers Squibb, where Ran acted as the Scientific Leader for various therapeutic areas, and positions at the University of Pennsylvania, Siemens Healthineers, The Ohio State University, and Tel Aviv University, emphasizing expertise in mass spectrometry, protein characterization, and molecular biology techniques. Educational qualifications include a Ph.D. in Microbiology from The Ohio State University and a Master’s and Bachelor’s degree in Microbiology and Life Sciences from Tel Aviv University.